Yahoo Web Search

Search results

1. • National Institutes of Health (NIH) to Open Long COVID Clinical Trials to Study Sleep Disturbances,...

     Sierra Sun Times· 6 days ago

     Part of the NIH RECOVER Initiative, trials will test four treatments. Please do not contact the NIH media phone number or email to enroll in these trials. May 10, 2024 - The National Institutes ...

2. • 

     Pipeline Moves: Phase III completion for Corcept’s relaorilant

     Clinical Trials Arena via Yahoo Finance· 4 days ago

     It can be calculated for a drug by considering characteristics like therapy area, indication and...

3. • Ozempic, Wegovy to be tested as alcohol-related liver disease therapies

     Becker’s Hospital Review· 2 days ago

     Novo Nordisk is investigating the potential of Ozempic, Wegovy's active ingredient and two other drug candidates as treatments for alcohol-related liver disease. The phase 2 trial will see how ...

4. • Rakuten Medical Announces Poster Presentation and Booth Exhibition at ASCO 2024 Annual Meeting

     WRBL Columbus· 7 days ago

     Disclaimer: Rakuten Medical's therapies based on Alluminox™ platform are investigational outside of Japan. SAN DIEGO, May 9, 2024 /PRNewswire/ -- Rakuten Medical, Inc., a global biotechnology ...

5. • Small Business - Cordele Dispatch | Cordele Dispatch

     Cordele Dispatch· 18 minutes ago

     The Data Monitoring Committee recommended to continue the clinical trial without modification of the current protocol, based on the pre-planned review of safety data. The recommendation was ...

6. • 

     Carisma Therapeutics begins trial for novel cancer therapy By Investing.com

     Investing.com· 6 hours ago

     Carisma Therapeutics Inc. (NASDAQ: CARM), a biopharmaceutical company, announced today the...

7. • 

     BioCorRx Reports Business Update for the First Quarter of 2024

     NewMediaWire via Yahoo Finance· 8 hours ago

     ANAHEIM, CA - (NewMediaWire) - May 16, 2024 - BioCorRx Inc. (OTCQB: BICX) (the "Company"), a...

8. • Small Business - The Andalusia Star-News | The Andalusia Star-News

     The Andalusia Star-News· 3 days ago

     Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases ...

9. • 

     Cardurion’s PDE9 inhibitor increases cGMP in Phase IIa heart failure trial

     Clinical Trials Arena via Yahoo Finance· 3 days ago

     Part A of the trial was completely successful. However, according to ClinicalTrials.gov, the second...

10. • CNS Pharmaceuticals Reports First Quarter 2024 Financial Results

      Digital Journal· 3 hours ago

      Enrollment completed in potentially pivotal GBM study evaluating Berubicin; Topline data expected in first half of 2025Company committed to addressing the most aggressive type of brain cancer ...